Works matching AU Chakraborty, S


Results: 470
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The BepiColombo Laser Altimeter.

    Published in:
    Space Science Reviews, 2021, v. 217, n. 1, p. 1, doi. 10.1007/s11214-021-00794-y
    By:
    • Thomas, N.;
    • Hussmann, H.;
    • Spohn, T.;
    • Lara, L. M.;
    • Christensen, U.;
    • Affolter, M.;
    • Bandy, T.;
    • Beck, T.;
    • Chakraborty, S.;
    • Geissbuehler, U.;
    • Gerber, M.;
    • Ghose, K.;
    • Gouman, J.;
    • HosseiniArani, S.;
    • Kuske, K.;
    • Peteut, A.;
    • Piazza, D.;
    • Rieder, M.;
    • Servonet, A.;
    • Althaus, C.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Ferrum Picricum.

    Published in:
    Homoeopathic Heritage, 2015, v. 41, n. 6, p. 40
    By:
    • Chakraborty, P. S.;
    • Singh, J. P.;
    • Rai, M. K.;
    • Singh, Pramodji;
    • Vichitra, A. K.;
    • Singh, A. K. N.;
    • Chakraborty, Deepa;
    • Singh, D. K.;
    • Singh, Hari;
    • Singh, Mohan;
    • Sinha, M. N.;
    • Singh, Rajpal;
    • Rai, R. K.;
    • Prakash, S.;
    • Pathak, S. D.;
    • Bhagat, S. R.;
    • Paul, Vijay K.;
    • Singh, V. K.;
    • Rai, Yogendar;
    • Siddiqui, V. A.
    Publication type:
    Article
    31
    32
    34
    35
    36
    37
    38

    Advances in Vasodilatory Shock: A Concise Review.

    Published in:
    Indian Journal of Critical Care Medicine, 2019, v. 23, n. 10, p. 475, doi. 10.5005/jp-journals-10071-23266
    By:
    • Lahiry, Sandeep;
    • Thakur, Sayanta;
    • Chakraborty, Dwaipayan S.
    Publication type:
    Article
    39
    40
    41
    42

    Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL).

    Published in:
    Hematological Oncology, 2023, v. 41, p. 575, doi. 10.1002/hon.3164_431
    By:
    • McDonald, A.;
    • Verburgh, E.;
    • Gotti, M.;
    • Pinto, A.;
    • Zaucha, J.;
    • Ivanov, V.;
    • Melnichenko, V.;
    • Mocikova, H.;
    • Ozcan, M.;
    • Patti, C.;
    • Farias, J.;
    • Goncalves, I.;
    • Kuchkova, O.;
    • Mayer, J.;
    • Saydam, G.;
    • Tomassetti, S.;
    • Pathiraja, K.;
    • Ryland, K.;
    • Chakraborty, S.;
    • Jurczak, W.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Avonex Combination Trial in relapsing-remitting MS: rationale, design and baseline data.

    Published in:
    Multiple Sclerosis (13524585), 2008, v. 14, n. 3, p. 370, doi. 10.1177/1352458507083189
    By:
    • Cohen, J. A.;
    • Calabresi, P. A.;
    • Chakraborty, S.;
    • Edwards, K. R.;
    • Eickenhorst, T.;
    • Felton III, W. L.;
    • Fisher, E.;
    • Fox, R. J.;
    • Goodman, A. D.;
    • Hara-Cleaver, C.;
    • Hutton, G. J.;
    • Imrey, P. B.;
    • Ivancic, D. M.;
    • Mandell, B. F.;
    • Perryman, J. E.;
    • Scott, T. F.;
    • Skaramagas, T. T.;
    • Zhang, H.
    Publication type:
    Article
    50